SAN DIEGO (AP) _ DexCom Inc. (DXCM) on Thursday reported a loss of $179.7 million in its fourth quarter.
On a per-share basis, the San Diego-based company said it had a loss of $2.03. Earnings, adjusted for non-recurring costs, were 54 cents per share.
The results exceeded Wall Street expectations. The average estimate of 11 analysts surveyed by Zacks Investment Research was for earnings of 16 cents per share.
The medical device company posted revenue of $338 million in the period, also beating Street forecasts. Four analysts surveyed by Zacks expected $330.8 million.
For the year, the company reported that its loss widened to $127.1 million, or $1.44 per share. Revenue was reported as $1.03 billion.
DexCom expects full-year revenue in the range of $1.18 billion to $1.23 billion.
DexCom shares have increased 22 percent since the beginning of the year. In the final minutes of trading on Thursday, shares hit $146.25, more than doubling in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on DXCM at https://www.zacks.com/ap/DXCM